BIN GUO to Humans
This is a "connection" page, showing publications BIN GUO has written about Humans.
Connection Strength
0.112
-
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS. Pharmacol Res. 2021 02; 164:105304.
Score: 0.018
-
Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells. Int J Mol Sci. 2020 Jun 30; 21(13).
Score: 0.018
-
Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2. Int J Mol Sci. 2020 Mar 27; 21(7).
Score: 0.018
-
RNA-based therapeutics for colorectal cancer: Updates and future directions. Pharmacol Res. 2020 02; 152:104550.
Score: 0.017
-
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci. 2019 Nov 16; 20(22).
Score: 0.017
-
Vitamin D and the Epigenetic Machinery in Colon Cancer. Curr Med Chem. 2017; 24(9):888-897.
Score: 0.014
-
A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells. Bioorg Chem. 2021 11; 116:105340.
Score: 0.005
-
"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Int J Mol Sci. 2021 Aug 20; 22(16).
Score: 0.005